Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Noradrenaline and cerebral aging].

M Jouvet1, J L Albarede, S Lubin

  • 1Laboratoire de Médecine Expérimentale, Faculté de Médecine, Lyon.

L'Encephale
|May 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical and neuropathologic study of a French family with a mutation in the neuroserpin gene.

Neurology·2007
Same author

[Type II split cord malformation of late clinical onset].

Revue neurologique·2004
Same author

[Burden experienced by informal caregivers assisting Alzheimer's patients in the REAL.FR study].

La Revue de medecine interne·2004
Same author

Mini Nutritional Assessment and Alzheimer patients.

Nestle Nutrition workshop series. Clinical & performance programme·2001
Same author

Instrumental activities of daily living as a potential marker of frailty: a study of 7364 community-dwelling elderly women (the EPIDOS study).

The journals of gerontology. Series A, Biological sciences and medical sciences·2001
Same author

Nutritional risk factors for institutional placement in Alzheimer's disease after one year follow-up.

The journal of nutrition, health & aging·2001
Same journal

Measuring antidepressant side effects in military personnel - Clinical validation of the French version of the UKU-SERS-Pat Scale: A comparative study of patient and clinician ratings.

L'Encephale·2026
Same journal

[Empowerment in addictology].

L'Encephale·2026
Same journal

Evaluation of the links between smoking and conspiracy mentality.

L'Encephale·2026
Same journal

Use of a relevance assessment tool in therapeutic residential care: A real world study.

L'Encephale·2026
Same journal

Prevalence and characteristics of domestic violence in a sample of adult psychiatric outpatients: A cross-sectional study.

L'Encephale·2026
Same journal

From representations to practice: how professionals describe supporting parents with psychiatric or somatic illness or disability.

L'Encephale·2026
See all related articles

Norepinephrine (NE) regulates alertness, sleep-wake cycles, attention, and cognitive functions. Its unique properties and involvement in neurological disorders suggest potential therapeutic benefits from NE-targeting medications.

Area of Science:

  • Neuroscience
  • Neurochemistry
  • Cognitive Science

Context:

  • The central noradrenergic system, utilizing norepinephrine (NE), plays a crucial role in cognitive functions and neurological processes.
  • Its unique anatomical and physiological characteristics enable it to act as a key interface between external stimuli and the central nervous system.

Purpose:

  • To elucidate the multifaceted functions of central norepinephrine (NE) in cognitive processes and neurological health.
  • To explore the involvement of the central noradrenergic system in aging, neurodegenerative diseases, and other neurological conditions.

Summary:

  • Norepinephrine (NE) is vital for alertness, sleep-wake cycles, attention, memory, learning, brain plasticity, and neuroprotection.
  • The central noradrenergic system's structure, including its extensive branching and neuromodulatory effects, facilitates cognitive information processing, particularly in the neocortex.

Related Experiment Videos

  • This system is implicated in the neurophysiology and clinical manifestations of cerebral aging, neurodegenerative disorders (e.g., Alzheimer's, Parkinson's), depression, and brain injuries.

    • Impact:

    • Recent advancements in NE-targeting medications, such as adrafinil and modafinil, show promise for improving multifactorial neurological and cognitive disorders.
    • Understanding the central noradrenergic system's role offers new therapeutic avenues for conditions characterized by cognitive decline and altered alertness.